Search
Search
Close this search box.

Join us for Medical Cannabis Week 2020

Since 2018, Business of Cannabis has produced Medical Cannabis Week to surface and celebrate insights and innovations from patients, practitioners and the industry. While a full week, in-person Medical Cannabis Week event was not possible in May 2020, we are moving ahead with a weeklong, virtual Medical Cannabis Week in November 2020.

Monday, November 16 – Day 1 | Patients + Practitioners

To start off Medical Cannabis Week, we will focus on patients and practitioners – including access to and efficacy of medical cannabis. Day 1 highlights include a conversation with Dr. Carolina Landolt of the Summertree Medical Clinic and the Science Advisory Committee of MediPharm Labs.


Tuesday, November 17 – Day 2 | Innovation + Research

This day of Medical Cannabis Week, will focus on innovation and research happening in the medical cannabis space, especially as it relates to Canada. Day 2 highlights include a presentation from Dr. Chris Talpas the Vice President, Quality and Scientific Affairs at MediPharm Labs. 


Wednesday, November 18 – Day 3 | Advocacy

As the medical cannabis program in Canada develops, understanding and supporting the patients – without whom there would be no industry – is critical. Along with Medical Cannabis Canada, this program will look at challenges for patients and the advocacy efforts to support them including a panel of patients sharing their experiences with the medical cannabis program in Canada.


Friday, November 20 – Day 5 | Cannabis + Sport

On the final day of Medical Cannabis Week, we will focus on the intersection of cannabis and sport – a topic gaining increased focus from current and retired athletes, doctors and trainers and policy makers and governing bodies. Day 5 will be anchored by a conversation with current and retired athletes as well as medical professionals and advocacy groups serving athletes. Day 5 is presented in conjunction with Athletes for Care.

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?